Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2015
Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study
Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Juan Virizuela Echaburu, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 6, 2025
DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid Cancer
Helena Rodríguez-Lloveras, Carles Zafon, Carmela Iglesias, et al.
Lancet (London, England)
|
July 2, 2026
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial
Thomas Walter, Henning Jann, Catherine Ansquer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2019
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study
Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Ángela Lamarca, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 28, 2020
Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus
Antonio Viúdez, Guillermo Crespo, María Luisa Gómez Dorronsoro, et al.
Endocrine-Related Cancer
|
March 17, 2023
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
British Journal of Cancer
|
May 18, 2016
A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia
Paula Jiménez Fonseca, Alberto Carmona-Bayonas, Ignacio Matos García, et al.
BMC Cancer
|
April 4, 2025
A Randomized clinical trial evaluating the impact on survival and quality of life of <sup>177</sup>Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)
Jaume Capdevila, Virginia Pubul, Urbano Anido, et al.
JAMA Oncology
|
July 10, 2025
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Alessandro Audisio, Chiara Gallio, Vaneja Velenik, et al.
The Lancet. Oncology
|
January 14, 2023
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study
Cédric Nesti, Konstantin Bräutigam, Marta Benavent, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2015
Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study
Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Juan Virizuela Echaburu, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 6, 2025
DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid Cancer
Helena Rodríguez-Lloveras, Carles Zafon, Carmela Iglesias, et al.
Lancet (London, England)
|
July 2, 2026
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial
Thomas Walter, Henning Jann, Catherine Ansquer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2019
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study
Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Ángela Lamarca, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 28, 2020
Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus
Antonio Viúdez, Guillermo Crespo, María Luisa Gómez Dorronsoro, et al.
Endocrine-Related Cancer
|
March 17, 2023
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
British Journal of Cancer
|
May 18, 2016
A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia
Paula Jiménez Fonseca, Alberto Carmona-Bayonas, Ignacio Matos García, et al.
BMC Cancer
|
April 4, 2025
A Randomized clinical trial evaluating the impact on survival and quality of life of <sup>177</sup>Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)
Jaume Capdevila, Virginia Pubul, Urbano Anido, et al.
JAMA Oncology
|
July 10, 2025
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Alessandro Audisio, Chiara Gallio, Vaneja Velenik, et al.
The Lancet. Oncology
|
January 14, 2023
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study
Cédric Nesti, Konstantin Bräutigam, Marta Benavent, et al.
Page
of 10